HER2 (human epidural growth factor receptor 2) positive breast cancer is an aggressive disease with an elevated risk of metastatic spread if appropriate treatment or therapy is not administered. While HER2 positive breast cancer recurrence affects some patients, recent advancements in targeted therapies and long-term treatment approaches have made relapse less likely than ever before. The majority of patients with HER2 positive cancer do not experience recurrence.
Despite these odds, you may still feel nervous about your chances of cancer recurrence if you have a history of HER2 positive breast cancer. This is completely understandable. The best way to calm your fears and reduce your risk is to be proactive about your breast health, complete all recommended treatments or therapies, and maintain regular follow-up with your breast cancer clinical care team.
Moffitt Cancer Center serves HER2 positive breast cancer survivors
Moffitt Cancer Center’s Don & Erika Wallace Comprehensive Breast Program offers advanced monitoring, preventive treatments and supportive care services to women and men with a history of HER2 positive breast cancer, including those who were treated at other hospitals and cancer centers. We encourage you to consult with one of our oncologists specializing in breast cancer if you have any concerns about your risk of recurrence.
Medically reviewed by Dr. Hatem Soliman
Fill out a new patient registration form online or call 1-888-663-3488 to reserve an appointment with a Moffitt physician. We encourage women and men with or without referrals to visit us for regular cancer screening and expert breast health advice.